Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis

Table. 1 Characteristics of studies included in systematic review and meta-analysis

Studies	Citation	Type of diabetes	Female proportion (%)	Mean age or range	Treatment modality	Sample size	Study design	Study site
Saeed, 2006	[20]	Type 2^a	56	55.66	Oral antidiabetic	97	cross sectional	Sudan
Haddadihneshad et al., 2010	[21]	type 1 & 2	57.7	12-67 (range)	insulin & oral antidiabetic	300	Cross sectional	Iran
Rosediani et al., 2006	[13]	Type 2	53.7	56.7	Oral antidiabetic	82	cross sectional^b	Malaysia
Swetha et al., 2014	[6]	Type 2	38.6	55.43	NS	1186	cross sectional	India
Gupta et al., 2014	[22]	Type 2	NS	NS	Oral antidiabetic	50	Cross sectional	Italy
Datta et al.,2014	[23]	type 1 & 2	53.3	51	Oral antidiabetic	120	cross sectional	India
Avignon et al., 1997	[24]	Type 2	36.3	40 - 78 (range)	Oral antidiabetic	66	cross sectional^b	France
Bonora et al., 2001	[25]	Type 2^a	43.1	59.5	Oral antidiabetic	371	cross sectional^b	Italy
Shrestha et al., 2012	[26]	Type 2	53.3	58.9	Oral antidiabetic	60	cross sectional^b	India
Azim et al., 2011	[27]	type 1 & 2	35.0	51.8	NS	71	cross sectional	Pakistan
Saiedullah et al., 2013	[28]	Type 2	44.1	48.4	Oral antidiabetic	177	cross section^b	Bangladesh
Woerle et al., 2007	[29]	Type 2	45.1	62.4	Insulin & antidiabetic	164	Prospective; intervention	Germany
Schernthaner et al., 2010	[30]	Type 2	46.4	56.7	Oral antidiabetic	973	cross sectional	Multi center
Monnier et al.,2003	[12]	Type 2^a	52.0	60.1	Oral antidiabetic	290	cross sectional	France

^a:constant diets and/or drugs were used for at least 3 months before the study; ^b:controlled or standardized meal before testing; NS not specified

ISSN: 2049-3258